Colistin Resistance Onset Strategies and Genomic Mosaicism in Clinical Acinetobacter baumannii Lineages

被引:3
|
作者
Cafiso, Viviana [1 ]
Stracquadanio, Stefano [1 ]
Dovere, Veronica [2 ]
Lo Verde, Flavia [1 ]
Zega, Alessandra [1 ]
Pigola, Giuseppe [1 ]
Barnini, Simona [3 ]
Ghelardi, Emilia [2 ]
Stefani, Stefania [1 ]
机构
[1] Univ Catania, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy
[2] Univ Pisa, Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, I-56126 Pisa, Italy
[3] Azienda Osped Univ Pisana, Bacteriol Unit, I-56126 Pisa, Italy
来源
PATHOGENS | 2021年 / 10卷 / 11期
关键词
A; baumannii; colistin resistance stability; genomic mosaicism; phylogenetic lineages; DAPTOMYCIN NONSUSCEPTIBILITY; HETERORESISTANCE; MECHANISMS; VIRULENCE;
D O I
10.3390/pathogens10111516
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The treatment of multidrug-resistant Gram-negative infections is based on colistin. As result, COL-resistance (COL-R) can develop and spread. In Acinetobacter baumannii, a crucial step is to understand COL-R onset and stability, still far to be elucidated. COL-R phenotypic stability, onset modalities, and phylogenomics were investigated in a clinical A. baumannii sample showing a COL resistant (COL(R)) phenotype at first isolation. COL-R was confirmed by Minimum-Inhibitory-Concentrations as well as investigated by Resistance-Induction assays and Population-Analysis-Profiles (PAPs) to determine: (i) stability; (ii) inducibility; (iii) heteroresistance. Genomics was performed by Mi-Seq Whole-Genome-Sequencing, Phylogenesis, and Genomic Epidemiology by bioinformatics. COL(R) A. baumannii were subdivided as follows: (i) 3 A. baumannii with stable and high COL MICs defining the "homogeneous-resistant " onset phenotype; (ii) 6 A. baumannii with variable and lower COL MICs displaying a "COL-inducible " onset phenotype responsible for adaptive-resistance or a "subpopulation " onset phenotype responsible for COL-heteroresistance. COL-R stability and onset strategies were not uniquely linked to the amount of LPS and cell envelope charge. Phylogenomics categorized 3 lineages clustering stable and/or unstable COL-R phenotypes with increasing genomic complexity. Likewise, different nsSNP profiling in genes already associated with COL-R marked the stable and/or unstable COL-R phenotypes. Our investigation finds out that A. baumannii can range through unstable or stable COL(R) phenotypes emerging via different "onset strategies " within phylogenetic lineages displaying increasing genomic mosaicism.
引用
收藏
页数:16
相关论文
共 50 条
  • [11] New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
    Sun, Bingbing
    Liu, Haiyan
    Jiang, Yu
    Shao, Lei
    Yang, Sheng
    Chen, Daijie
    MSPHERE, 2020, 5 (02)
  • [12] Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
    Carretero-Ledesma, Marta
    Garcia-Quintanilla, Meritxell
    Martin-Pena, Reyes
    Pulido, Marina R.
    Pachon, Jeronimo
    McConnell, Michael J.
    VIRULENCE, 2018, 9 (01) : 930 - 942
  • [13] A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii
    Dahdouh, Elias
    Gomez-Gil, Rosa
    Sanz, Sonia
    Gonzalez-Zorn, Bruno
    Daoud, Ziad
    Mingorance, Jesus
    Suarez, Monica
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 727 - 733
  • [14] In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
    Owen, Roxanne J.
    Li, Jian
    Nation, Roger L.
    Spelman, Denis
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 473 - 477
  • [15] Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation
    Dafopoulou, Konstantina
    Xavier, Basil Britto
    Hotterbeekx, An
    Janssens, Lore
    Lammens, Christine
    De, Emmanuelle
    Goossens, Herman
    Tsakris, Athanasios
    Malhotra-Kumar, Surbhi
    Pournaras, Spyros
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1892 - 1895
  • [16] Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates
    Girardello, Raquel
    Visconde, Marina
    Cayo, Rodrigo
    Bressan Queiroz de Figueiredo, Regina Celia
    da Silva Mori, Marcelo Alves
    Lincopan, Nilton
    Gales, Ana Cristina
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (01) : 37 - 44
  • [17] The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications
    Nguyen Thi Khanh Nhu
    Riordan, David W.
    Tran Do Hoang Nhu
    Duy Pham Thanh
    Thwaites, Guy
    Nguyen Phu Huong Lan
    Wren, Brendan W.
    Baker, Stephen
    Stabler, Richard A.
    SCIENTIFIC REPORTS, 2016, 6
  • [18] Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
    Moffatt, Jennifer H.
    Harper, Marina
    Harrison, Paul
    Hale, John D. F.
    Vinogradov, Evgeny
    Seemann, Torsten
    Henry, Rebekah
    Crane, Bethany
    Michael, Frank St.
    Cox, Andrew D.
    Adler, Ben
    Nation, Roger L.
    Li, Jian
    Boyce, John D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) : 4971 - 4977
  • [19] The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
    Mu, Xinli
    Wang, Nanfei
    Li, Xi
    Shi, Keren
    Zhou, Zhihui
    Yu, Yunsong
    Hua, Xiaoting
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [20] Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
    Park, Yu Jin
    Hong, Duck Jin
    Yoon, Eun-Jeong
    Kim, Dokyun
    Choi, Min Hyuk
    Hong, Jun Sung
    Lee, Hyukmin
    Yong, Dongeun
    Jeong, Seok Hoon
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (06) : 545 - 554